DUBUQUE BANK & TRUST CO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
DUBUQUE BANK & TRUST CO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$224,000
-23.5%
1,6000.0%0.04%
-23.4%
Q2 2019$293,000
+15.4%
1,6000.0%0.05%
+14.6%
Q1 2019$254,000
+66.0%
1,6000.0%0.04%
+46.4%
Q4 2018$153,000
-32.3%
1,6000.0%0.03%
-20.0%
Q3 2018$226,000
-9.6%
1,6000.0%0.04%
-14.6%
Q2 2018$250,000
-13.8%
1,600
-11.1%
0.04%
-12.8%
Q1 2018$290,000
-2.7%
1,800
-0.6%
0.05%
+4.4%
Q4 2017$298,000
+127.5%
1,810
-13.8%
0.04%
+104.5%
Q3 2017$131,000
-21.6%
2,1000.0%0.02%
-38.9%
Q2 2017$167,0002,1000.04%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders